Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-induced Alopecia: a Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosed with gynecological cancer (endometrium, cervix, ovarian or vulva) or breast cancer
• Receiving chemotherapy ((Carbo)-Taxol)
• Age ≥ 18 years
• Able to comply to the study protocol
• Able to sign written informed consent
Locations
Other Locations
Belgium
Jessa Hospital
RECRUITING
Hasselt
Contact Information
Primary
Jeroen Mebis, Prof. Dr.
jeroen.mebis@jessazh.be
+32 11 33 72 21
Backup
Marithé Claes, MSc
marithe.claes@uhasselt.be
+32 11 33 72 39
Time Frame
Start Date: 2022-02-28
Estimated Completion Date: 2030-01
Participants
Target number of participants: 72
Treatments
Experimental: Treatment group
Patients allocated to the treatment group will receive scalp cooling combined with thrice weekly PBM sessions during the CTx course and until one month after the end of CTx.
Active_comparator: Control group
Patients allocated to the control group will receive scalp cooling during their CTx course.
Related Therapeutic Areas
Sponsors
Leads: Jessa Hospital